サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1591333

臨床意思決定支援システムの世界市場：コンポーネント・製品・モデル・デリバリーモード・助言モード・設定・タイプ・用途・地域別の予測 (～2032年)

Global Clinical Decision Support System Market Research Report Information by Component By Product, By Model, By Delivery Mode, By Mode of Advice, By Setting By Type, By Application, By Region - Forecast till 2032

出版日
ページ情報
英文 184 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
臨床意思決定支援システムの世界市場：コンポーネント・製品・モデル・デリバリーモード・助言モード・設定・タイプ・用途・地域別の予測 (～2032年)
出版日: 2024年10月20日
発行: Market Research Future
ページ情報: 英文 184 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

臨床意思決定支援システムの市場規模は、予測期間中に10.54％のCAGRで推移し、2024年の36億7,000万米ドルから、2032年には89億2,000万米ドルの規模に成長すると予測されています。同市場は、高齢者人口の増加、有利な政府規制、データ駆動型技術への需要の高まりにより成長を遂げています。

老年人口は慢性疾患にかかりやすく、頻繁な診察と介入が必要となります。その結果、医療機関の負担は老年人口の増加によって悪化しています。このため、効率的な医療の提供を保証するCDSSなどの技術に対する需要が高まっています。例えば、国連は2050年までに世界の6人に1人が65歳以上になると予測しており、これは2019年の11人に1人から大幅に増加します。Rural Health Information Hubによれば、米国では2050年までに65歳以上の高齢者が9,000万人近くまで増加すると予測されています。また、2030年には米国人の5人に1人が65歳以上になると予測されています。

地域別展望

北米の臨床意思決定支援システム市場は2023年に最大の市場シェアを占めました。これは、北米地域でがん、心血管障害、糖尿病、肥満、関節炎などの慢性疾患の発生率が上昇している結果です。欧州では、高度な治療施設へのアクセスが可能なことから、臨床意思決定支援システム市場が2番目に高い市場シェアを占めています。アジア太平洋地域は、同地域における患者人口の増加、ヘルスケアインフラの改善、がん、整形外科疾患、心血管疾患などの慢性疾患の流行により、大幅な成長が見込まれています。

当レポートでは、世界の臨床意思決定支援システムの市場を調査し、市場の定義と概要、市場成長への各種影響因子の分析、市場規模の推移・予測、各種区分・地域/主要国別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

第3章 調査手法

第4章 市場力学

  • 促進要因
    • 高齢化人口の増加
    • 政府の有利な規制
    • データ駆動型技術の需要の高まり
  • 抑制要因
    • データプライバシーのリスク
    • 導入コストが高い
  • 機会
    • ヘルスケアIT分野の進歩

第5章 市場要因分析

  • バリューチェーン分析
  • ポーターのファイブフォース分析
  • COVID-19が世界の臨床意思決定支援システム市場に与える影響

第6章 世界の臨床意思決定支援システム市場：コンポーネント別

  • 概要
  • ソフトウェア
  • サービス
  • ハードウェア

第7章 世界の臨床意思決定支援システム市場：製品別

  • 概要
  • 統合CDSS
  • スタンドアロンCDSS

第8章 世界の臨床意思決定支援システム市場：モデル別

  • 概要
  • 知識ベースCDSS
  • 非知識ベースCDSS

第9章 世界の臨床意思決定支援システム市場：デリバリーモード別

  • 概要
  • オンプレミスCDSS
  • クラウドベースCDSS

第10章 世界の臨床意思決定支援システム市場：助言モード別

  • 概要
  • アクティブCDSS
  • パッシブCDSS

第11章 世界の臨床意思決定支援システム市場：設定別

  • 概要
  • 入院患者
  • 外来診療環境

第12章 世界の臨床意思決定支援システム市場：タイプ別

  • 概要
  • 治療用CDSS
  • 診断用CDSS

第13章 世界の臨床意思決定支援システム市場：用途別

  • 概要
  • 高度なCDSS
  • 従来のCDSS

第14章 世界の臨床意思決定支援システム市場：地域別

  • 概要
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第15章 競合情勢

  • 市場シェア分析
  • 競合ダッシュボード
  • 公開企業の株式概要
  • 比較分析：主要企業の財務動向
  • 主な展開・成長戦略

第16章 企業プロファイル

  • SIEMENS
  • VERADIGM LLC（ALLSCRIPTS HEALTHCARE SOLUTIONS INC）
  • ORACLE CORPORATION
  • IBM
  • CARESTREAM HEALTH
  • WOLTERS KLUWER N.V.
  • EPIC SYSTEMS CORPORATION
  • CHANG HEALTHCARE
  • MEDICAL INFORMATION TECHNOLOGY, INC.
  • COMPUTER PROGRAMS AND SYSTEMS, INC.

第17章 データの引用

図表

LIST OF TABLES

  • TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT
  • TABLE 2 GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET, BY COMPONENT, 2019-2032 (USD BILLION)
  • TABLE 3 GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET, FOR SOFTWARE, BY REGION, 2019-2032 (USD BILLION)
  • TABLE 4 GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET, FOR SERVICES, BY REGION, 2019-2032 (USD BILLION)
  • TABLE 5 GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET, FOR HARDWARE, BY REGION, 2019-2032 (USD BILLION)
  • TABLE 6 GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 7 GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET, FOR INTEGRATED CDSS, BY REGION, 2019-2032 (USD BILLION)
  • TABLE 8 GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET, FOR STANDALONE CDSS, BY REGION, 2019-2032 (USD BILLION)
  • TABLE 9 GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET, BY MODEL, 2019-2032 (USD BILLION)
  • TABLE 10 GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET, FOR KNOWLEDGE-BASED CDSS, BY REGION, 2019-2032 (USD BILLION)
  • TABLE 11 GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET, FOR NON-KNOWLEDGE-BASED CDSS, BY REGION, 2019-2032 (USD BILLION)
  • TABLE 12 GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET, BY DELIVERY MODE, 2019-2032 (USD BILLION)
  • TABLE 13 GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET, FOR ON-PREMISE CDSS, BY REGION, 2019-2032 (USD BILLION)
  • TABLE 14 GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET, FOR CLOUD-BASED CDSS, BY REGION, 2019-2032 (USD BILLION)
  • TABLE 15 GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET, BY MODE OF ADVICE, 2019-2032 (USD BILLION)
  • TABLE 16 GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET, FOR ACTIVE CDSS, BY REGION, 2019-2032 (USD BILLION)
  • TABLE 17 GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET, FOR PASSIVE CDSS, BY REGION, 2019-2032 (USD BILLION)
  • TABLE 18 GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET, BY SETTING, 2019-2032 (USD BILLION)
  • TABLE 19 GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET, FOR INPATIENT SETTINGS, BY REGION, 2019-2032 (USD BILLION)
  • TABLE 20 GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET, FOR AMBULATORY CARE SETTINGS, BY REGION, 2019-2032 (USD BILLION)
  • TABLE 21 GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 22 GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET, FOR THERAPEUTIC CDSS, BY REGION, 2019-2032 (USD BILLION)
  • TABLE 23 GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET, FOR DIAGNOSTIC CDSS, BY REGION, 2019-2032 (USD BILLION)
  • TABLE 24 GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 25 GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET, FOR ADVANCED CDSS, BY REGION, 2019-2032 (USD BILLION)
  • TABLE 26 GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET, FOR CONVENTIONAL CDSS, BY REGION, 2019-2032 (USD BILLION)
  • TABLE 27 GLOBAL: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY REGION, 2019-2032 (USD BILLION)
  • TABLE 28 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY COUNTRY, 2019-2032 (USD BILLION)
  • TABLE 29 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY COMPONENT, 2019-2032 (USD BILLION)
  • TABLE 30 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 31 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY MODEL, 2019-2032 (USD BILLION)
  • TABLE 32 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY DELIVERY MODE, 2019-2032 (USD BILLION)
  • TABLE 33 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY MODE OF ADVICE, 2019-2032 (USD BILLION)
  • TABLE 34 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY SETTING, 2019-2032 (USD BILLION)
  • TABLE 35 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 36 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 37 US: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY COMPONENT, 2019-2032 (USD BILLION)
  • TABLE 38 US: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 39 US: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY MODEL, 2019-2032 (USD BILLION)
  • TABLE 40 US: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY DELIVERY MODE, 2019-2032 (USD BILLION)
  • TABLE 41 US: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY MODE OF ADVICE, 2019-2032 (USD BILLION)
  • TABLE 42 US: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY SETTING, 2019-2032 (USD BILLION)
  • TABLE 43 US: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 44 US: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 45 CANADA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY COMPONENT, 2019-2032 (USD BILLION)
  • TABLE 46 CANADA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 47 CANADA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY MODEL, 2019-2032 (USD BILLION)
  • TABLE 48 CANADA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY DELIVERY MODE, 2019-2032 (USD BILLION)
  • TABLE 49 CANADA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY MODE OF ADVICE, 2019-2032 (USD BILLION)
  • TABLE 50 CANADA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY SETTING, 2019-2032 (USD BILLION)
  • TABLE 51 CANADA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 52 CANADA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 53 EUROPE: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY COUNTRY, 2019-2032 (USD BILLION)
  • TABLE 54 EUROPE: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY COMPONENT, 2019-2032 (USD BILLION)
  • TABLE 55 EUROPE: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 56 EUROPE: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY MODEL, 2019-2032 (USD BILLION)
  • TABLE 57 EUROPE: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY DELIVERY MODE, 2019-2032 (USD BILLION)
  • TABLE 58 EUROPE: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY MODE OF ADVICE, 2019-2032 (USD BILLION)
  • TABLE 59 EUROPE: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY SETTING, 2019-2032 (USD BILLION)
  • TABLE 60 EUROPE: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 61 EUROPE: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 62 GERMANY: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY COMPONENT, 2019-2032 (USD BILLION)
  • TABLE 63 GERMANY: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 64 GERMANY: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY MODEL, 2019-2032 (USD BILLION)
  • TABLE 65 GERMANY: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY DELIVERY MODE, 2019-2032 (USD BILLION)
  • TABLE 66 GERMANY: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY MODE OF ADVICE, 2019-2032 (USD BILLION)
  • TABLE 67 GERMANY: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY SETTING, 2019-2032 (USD BILLION)
  • TABLE 68 GERMANY: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 69 GERMANY: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 70 FRANCE: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY COMPONENT, 2019-2032 (USD BILLION)
  • TABLE 71 FRANCE: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 72 FRANCE: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY MODEL, 2019-2032 (USD BILLION)
  • TABLE 73 FRANCE: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY DELIVERY MODE, 2019-2032 (USD BILLION)
  • TABLE 74 FRANCE: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY MODE OF ADVICE, 2019-2032 (USD BILLION)
  • TABLE 75 FRANCE: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY SETTING, 2019-2032 (USD BILLION)
  • TABLE 76 FRANCE: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 77 FRANCE: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 78 UK: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY COMPONENT, 2019-2032 (USD BILLION)
  • TABLE 79 UK: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 80 UK: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY MODEL, 2019-2032 (USD BILLION)
  • TABLE 81 UK: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY DELIVERY MODE, 2019-2032 (USD BILLION)
  • TABLE 82 UK: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY MODE OF ADVICE, 2019-2032 (USD BILLION)
  • TABLE 83 UK: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY SETTING, 2019-2032 (USD BILLION)
  • TABLE 84 UK: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 85 UK: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 86 ITALY: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY COMPONENT, 2019-2032 (USD BILLION)
  • TABLE 87 ITALY: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 88 ITALY: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY MODEL, 2019-2032 (USD BILLION)
  • TABLE 89 ITALY: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY DELIVERY MODE, 2019-2032 (USD BILLION)
  • TABLE 90 ITALY: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY MODE OF ADVICE, 2019-2032 (USD BILLION)
  • TABLE 91 ITALY: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY SETTING, 2019-2032 (USD BILLION)
  • TABLE 92 ITALY: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 93 ITALY: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 94 SPAIN: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY COMPONENT, 2019-2032 (USD BILLION)
  • TABLE 95 SPAIN: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 96 SPAIN: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY MODEL, 2019-2032 (USD BILLION)
  • TABLE 97 SPAIN: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY DELIVERY MODE, 2019-2032 (USD BILLION)
  • TABLE 98 SPAIN: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY MODE OF ADVICE, 2019-2032 (USD BILLION)
  • TABLE 99 SPAIN: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY SETTING, 2019-2032 (USD BILLION)
  • TABLE 100 SPAIN: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 101 SPAIN: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 102 REST OF EUROPE: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY COMPONENT, 2019-2032 (USD BILLION)
  • TABLE 103 REST OF EUROPE: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 104 REST OF EUROPE: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY MODEL, 2019-2032 (USD BILLION)
  • TABLE 105 REST OF EUROPE: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY DELIVERY MODE, 2019-2032 (USD BILLION)
  • TABLE 106 REST OF EUROPE: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY MODE OF ADVICE, 2019-2032 (USD BILLION)
  • TABLE 107 REST OF EUROPE: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY SETTING, 2019-2032 (USD BILLION)
  • TABLE 108 REST OF EUROPE: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 109 REST OF EUROPE: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 110 ASIA-PACIFIC: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY COUNTRY, 2019-2032 (USD BILLION)
  • TABLE 111 ASIA-PACIFIC: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY COMPONENT, 2019-2032 (USD BILLION)
  • TABLE 112 ASIA-PACIFIC: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 113 ASIA-PACIFIC: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY MODEL, 2019-2032 (USD BILLION)
  • TABLE 114 ASIA-PACIFIC: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY DELIVERY MODE, 2019-2032 (USD BILLION)
  • TABLE 115 ASIA-PACIFIC: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY MODE OF ADVICE, 2019-2032 (USD BILLION)
  • TABLE 116 ASIA-PACIFIC: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY SETTING, 2019-2032 (USD BILLION)
  • TABLE 117 ASIA-PACIFIC: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 118 ASIA-PACIFIC: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 119 CHINA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY COMPONENT, 2019-2032 (USD BILLION)
  • TABLE 120 CHINA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 121 CHINA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY MODEL, 2019-2032 (USD BILLION)
  • TABLE 122 CHINA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY DELIVERY MODE, 2019-2032 (USD BILLION)
  • TABLE 123 CHINA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY MODE OF ADVICE, 2019-2032 (USD BILLION)
  • TABLE 124 CHINA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY SETTING, 2019-2032 (USD BILLION)
  • TABLE 125 CHINA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 126 CHINA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 127 JAPAN: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY COMPONENT, 2019-2032 (USD BILLION)
  • TABLE 128 JAPAN: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 129 JAPAN: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY MODEL, 2019-2032 (USD BILLION)
  • TABLE 130 JAPAN: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY DELIVERY MODE, 2019-2032 (USD BILLION)
  • TABLE 131 JAPAN: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY MODE OF ADVICE, 2019-2032 (USD BILLION)
  • TABLE 132 JAPAN: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY SETTING, 2019-2032 (USD BILLION)
  • TABLE 133 JAPAN: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 134 JAPAN: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 135 INDIA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY COMPONENT, 2019-2032 (USD BILLION)
  • TABLE 136 INDIA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 137 INDIA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY MODEL, 2019-2032 (USD BILLION)
  • TABLE 138 INDIA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY DELIVERY MODE, 2019-2032 (USD BILLION)
  • TABLE 139 INDIA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY MODE OF ADVICE, 2019-2032 (USD BILLION)
  • TABLE 140 INDIA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY SETTING, 2019-2032 (USD BILLION)
  • TABLE 141 INDIA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 142 INDIA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 143 AUSTRALIA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY COMPONENT, 2019-2032 (USD BILLION)
  • TABLE 144 AUSTRALIA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 145 AUSTRALIA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY MODEL, 2019-2032 (USD BILLION)
  • TABLE 146 AUSTRALIA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY DELIVERY MODE, 2019-2032 (USD BILLION)
  • TABLE 147 AUSTRALIA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY MODE OF ADVICE, 2019-2032 (USD BILLION)
  • TABLE 148 AUSTRALIA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY SETTING, 2019-2032 (USD BILLION)
  • TABLE 149 AUSTRALIA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 150 AUSTRALIA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 151 SOUTH KOREA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY COMPONENT, 2019-2032 (USD BILLION)
  • TABLE 152 SOUTH KOREA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 153 SOUTH KOREA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY MODEL, 2019-2032 (USD BILLION)
  • TABLE 154 SOUTH KOREA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY DELIVERY MODE, 2019-2032 (USD BILLION)
  • TABLE 155 SOUTH KOREA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY MODE OF ADVICE, 2019-2032 (USD BILLION)
  • TABLE 156 SOUTH KOREA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY SETTING, 2019-2032 (USD BILLION)
  • TABLE 157 SOUTH KOREA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 158 SOUTH KOREA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 159 REST OF ASIA-PACIFIC: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY COMPONENT, 2019-2032 (USD BILLION)
  • TABLE 160 REST OF ASIA-PACIFIC: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 161 REST OF ASIA-PACIFIC: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY MODEL, 2019-2032 (USD BILLION)
  • TABLE 162 REST OF ASIA-PACIFIC: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY DELIVERY MODE, 2019-2032 (USD BILLION)
  • TABLE 163 REST OF ASIA-PACIFIC: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY MODE OF ADVICE, 2019-2032 (USD BILLION)
  • TABLE 164 REST OF ASIA-PACIFIC: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY SETTING, 2019-2032 (USD BILLION)
  • TABLE 165 REST OF ASIA-PACIFIC: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 166 REST OF ASIA-PACIFIC: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 167 REST OT THE WORLD: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY REGION, 2019-2032 (USD BILLION)
  • TABLE 168 REST OF THE WORLD: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY COMPONENT, 2019-2032 (USD BILLION)
  • TABLE 169 REST OF THE WORLD: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 170 REST OF THE WORLD: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY MODEL, 2019-2032 (USD BILLION)
  • TABLE 171 REST OF THE WORLD: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY DELIVERY MODE, 2019-2032 (USD BILLION)
  • TABLE 172 REST OF THE WORLD: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY MODE OF ADVICE, 2019-2032 (USD BILLION)
  • TABLE 173 REST OF THE WORLD: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY SETTING, 2019-2032 (USD BILLION)
  • TABLE 174 REST OF THE WORLD: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 175 REST OF THE WORLD: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 176 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY COMPONENT, 2019-2032 (USD BILLION)
  • TABLE 177 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 178 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY MODEL, 2019-2032 (USD BILLION)
  • TABLE 179 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY DELIVERY MODE, 2019-2032 (USD BILLION)
  • TABLE 180 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY MODE OF ADVICE, 2019-2032 (USD BILLION)
  • TABLE 181 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY SETTING, 2019-2032 (USD BILLION)
  • TABLE 182 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 183 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 184 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY COMPONENT, 2019-2032 (USD BILLION)
  • TABLE 185 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 186 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY MODEL, 2019-2032 (USD BILLION)
  • TABLE 187 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY DELIVERY MODE, 2019-2032 (USD BILLION)
  • TABLE 188 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY MODE OF ADVICE, 2019-2032 (USD BILLION)
  • TABLE 189 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY SETTING, 2019-2032 (USD BILLION)
  • TABLE 190 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 191 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 192 PUBLIC PLAYERS STOCK SUMMARY
  • TABLE 193 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
  • TABLE 194 PRODUCT /PRODUCT/SOLUTION/SERVICE LAUNCH APPROVAL
  • TABLE 195 COLLABORATION
  • TABLE 196 ACQUISITION
  • TABLE 197 PARTNERSHIP
  • TABLE 198 SIEMENS: PRODUCTS OFFERED
  • TABLE 199 VERADIGM LLC (ALLSCRIPTS HEALTHCARE SOLUTIONS INC): PRODUCTS/SERVICE/SOLUTION OFFERED
  • TABLE 200 VERADIGM LLC (ALLSCRIPTS HEALTHCARE SOLUTIONS INC): KEY DEVELOPMENTS
  • TABLE 201 ORACLE CORPORATION: PRODCUTS OFFERED
  • TABLE 202 ORACLE CORPORATION: KEY DEVELOPMENTS
  • TABLE 203 IBM: SOLUTION OFFERED
  • TABLE 204 IBM: KEY DEVELOPMENTS
  • TABLE 205 CARESTREAM HEALTH: SERVICE/SOLUTION OFFERED
  • TABLE 206 WOLTERS KLUWER N.V.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 207 EPIC SYSTEMS CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 208 CHANG HEALTHCARE: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 209 MEDICAL INFORMATION TECHNOLOGY, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 210 COMPUTER PROGRAMS AND SYSTEMS, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED

LIST OF FIGURES

  • FIGURE 1 GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET: STRUCTURE
  • FIGURE 2 GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET: MARKET GROWTH FACTOR ANALYSIS (2023-2032)
  • FIGURE 3 DRIVER IMPACT ANALYSIS (2023-2032)
  • FIGURE 4 RESTRAINT IMPACT ANALYSIS (2023-2032)
  • FIGURE 5 VALUE CHAIN ANALYSIS OF THE GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET
  • FIGURE 6 PORTER'S FIVE FORCES ANALYSIS: GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET
  • FIGURE 7 GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET, COMPONENT SEGMENT ATTRACTIVENESS, 2019-2032 (USD BILLION)
  • FIGURE 8 GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET, BY COMPONENT, 2023 & 2032 (USD BILLION)
  • FIGURE 9 GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET SHARE (%), BY COMPONENT,
  • FIGURE 10 GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET, PRODUCT SEGMENT ATTRACTIVENESS, 2019-2032 (USD BILLION)
  • FIGURE 11 GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET, BY PRODUCT, 2023 & 2032 (USD BILLION)
  • FIGURE 12 GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET SHARE (%), BY PRODUCT,
  • FIGURE 13 GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET, MODEL SEGMENT ATTRACTIVENESS, 2019-2032 (USD BILLION)
  • FIGURE 14 GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET, BY MODEL, 2023 & 2032 (USD BILLION)
  • FIGURE 15 GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET SHARE (%), BY MODEL,
  • FIGURE 16 GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET, DELIVERY MODE SEGMENT ATTRACTIVENESS, 2019-2032 (USD BILLION)
  • FIGURE 17 GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET, BY DELIVERY MODE, 2023 & 2032 (USD BILLION)
  • FIGURE 18 GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET SHARE (%), BY DELIVERY MODE,
  • FIGURE 19 GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET, MODE OF ADVICE SEGMENT ATTRACTIVENESS, 2019-2032 (USD BILLION)
  • FIGURE 20 GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET, BY MODE OF ADVICE, 2023 & 2032 (USD BILLION)
  • FIGURE 21 GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET SHARE (%), BY MODE OF ADVICE,
  • FIGURE 22 GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET, SETTING SEGMENT ATTRACTIVENESS, 2019-2032 (USD BILLION)
  • FIGURE 23 GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET, BY SETTING, 2023 & 2032 (USD BILLION)
  • FIGURE 24 GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET SHARE (%), BY SETTING,
  • FIGURE 25 GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET, TYPE SEGMENT ATTRACTIVENESS, 2019-2032 (USD BILLION)
  • FIGURE 26 GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET, BY TYPE, 2023 & 2032 (USD BILLION)
  • FIGURE 27 GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET SHARE (%), BY TYPE,
  • FIGURE 28 GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET, APPLICATION SEGMENT ATTRACTIVENESS, 2019-2032 (USD BILLION)
  • FIGURE 29 GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET, BY APPLICATION, 2023 & 2032 (USD BILLION)
  • FIGURE 30 GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET SHARE (%), BY APPLICATION,
  • FIGURE 31 GLOBAL: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY REGION, 2023 & 2032 (USD BILLION)
  • FIGURE 32 GLOBAL: CLINICAL DECISION SUPPORT SYSTEM MARKET SHARE (%), BY REGION,
  • FIGURE 33 NORTH AMERICA MARKET ANALYSIS: CLINICAL DECISION SUPPORT SYSTEM MARKET, 2019-2032 (USD BILLION)
  • FIGURE 34 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY COUNTRY, 2023 & 2032 (USD BILLION)
  • FIGURE 35 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEM MARKET SHARE (%), BY COUNTRY,
  • FIGURE 36 EUROPE MARKET ANALYSIS: CLINICAL DECISION SUPPORT SYSTEM MARKET, 2019-2032 (USD BILLION)
  • FIGURE 37 EUROPE: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY COUNTRY, 2023 & 2032 (USD BILLION)
  • FIGURE 38 EUROPE: CLINICAL DECISION SUPPORT SYSTEM MARKET SHARE (%), BY COUNTRY,
  • FIGURE 39 ASIA-PACIFIC MARKET ANALYSIS: CLINICAL DECISION SUPPORT SYSTEM MARKET, 2019-2032 (USD BILLION)
  • FIGURE 40 ASIA-PACIFIC: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY COUNTRY, 2023 & 2032 (USD BILLION)
  • FIGURE 41 ASIA-PACIFIC: CLINICAL DECISION SUPPORT SYSTEM MARKET SHARE (%), BY COUNTRY,
  • FIGURE 42 REST OF THE WORLD MARKET ANALYSIS: CLINICAL DECISION SUPPORT SYSTEM MARKET, 2019-2032 (USD BILLION)
  • FIGURE 43 REST OT THE WORLD: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY REGION, 2023 & 2032 (USD BILLION)
  • FIGURE 44 REST OT THE WORLD: CLINICAL DECISION SUPPORT SYSTEM MARKET SHARE (%), BY REGION,
  • FIGURE 45 CLINICAL DECISION SUPPORT SYSTEM (CDSS) MARKET PLAYERS: COMPETITIVE ANALSIS,
  • FIGURE 46 COMPETITOR DASHBOARD: GLOBAL CLINICAL DECISION SUPPORT SYSTEM (CDSS) MARKET
  • FIGURE 47 SIEMENS: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 48 SIEMENS: SWOT ANALYSIS
  • FIGURE 49 VERADIGM LLC (ALLSCRIPTS HEALTHCARE SOLUTIONS INC): FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 50 VERADIGM LLC (ALLSCRIPTS HEALTHCARE SOLUTIONS INC): SWOT ANALYSIS
  • FIGURE 51 ORACLE CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 52 IBM: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 53 IBM: SWOT ANALYSIS
  • FIGURE 54 WOLTERS KLUWER N.V.: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 55 WOLTERS KLUWER N.V.: SWOT ANALYSIS
  • FIGURE 56 EPIC SYSTEMS CORPORATION: SWOT ANALYSIS
  • FIGURE 57 COMPUTER PROGRAMS AND SYSTEMS, INC.: FINANCIAL OVERVIEW SNAPSHOT
目次
Product Code: MRFR/HCIT/4580-CR

Global Clinical Decision Support System Market Research Report Information by Component (Software, Services, and Hardware) By Product (Integrated CDSS and Standalone CDSS), By Model (Knowledge-Based CDSS and Non-Knowledge-Based CDSS), By Delivery Mode (On-Premise CDSS and Cloud-Based CDSS), By Mode of Advice (Active CDSS and Passive CDSS), By Setting (Inpatient Settings and Ambulatory Care Settings) By Type (Therapeutic Clinical Decision Support Systems and Diagnostic Clinical Decision Support Systems ), By Application (Advanced Clinical Decision Support Systems and Conventional Clinical Decision Support Systems), By Region (North America, Europe, Asia-Pacific, and Rest of the World) - Forecast till 2032

Market Overview

The clinical decision support system market industry is anticipated to experience a compound annual growth rate (CAGR) of 10.54% during the forecast period, increasing from USD 3.67 billion in 2024 to USD 8.92 billion by 2032. The market is experiencing growth due to the increasing geriatric population, favorable government regulations, and the increasing demand for data-driven technologies.

The geriatric population is more susceptible to chronic diseases and necessitates frequent medical examinations and interventions. Consequently, the burden on healthcare institutions is exacerbated by the growing geriatric population. This drives the demand for technologies like CDSS to ensure the provision of efficient care. For instance, the United Nations predicts that by 2050, one in six individuals worldwide will be over the age of 65, a significant increase from one in eleven in 2019. The number of senior adults aged 65 and older is anticipated to increase to nearly 90 million in the United States by 2050, as per the Rural Health Information Hub. In addition, it is anticipated that by 2030, one in five Americans will be 65 years of age or older.

Market segment insights

Software, services, and hardware comprise the Clinical Decision Support System Market segmentation, which is based on component.

The market segmentation is determined by the products, which include Standalone CDSS and Integrated CDSS.

The market segmentation is predicated on a model that encompasses both knowledge-based and non-knowledge-based CDSS.

The Clinical Decision Support System Market segmentation is determined by the delivery mode, which encompasses On-Premises CDSS and Cloud-Based CDSS.

The market segmentation is determined by the mode of advice, which encompasses Active CDSS and Passive CDSS.

On the basis of setting, the market segmentation encompasses both inpatient and ambulatory care contexts.

Therapeutic clinical decision support systems and diagnostic clinical decision support systems comprise the Clinical Decision Support System Market segmentation.

The market segmentation is determined by the application, which encompasses both conventional and advanced clinical decision support systems.

Regional Perspectives

In 2023, the clinical decision support system market in North America held the greatest market share. This is a result of the rising incidence of chronic diseases in the North American region, including cancer, cardiovascular disorders, diabetes, obesity, and arthritis.

In Europe, the clinical decision support system market is the second highest market share, as a result of the region's access to advanced treatment facilities.

The Asia-Pacific clinical decision support system market is anticipated to experience substantial growth as a result of the growing patient population in the region, as well as the improvement of healthcare infrastructure and the prevalence of chronic diseases such as cancer, orthopedic, and cardiovascular diseases.

Major Players

Siemens (Germany), Veradigm LLC (Allscripts Healthcare Solutions Inc) (US), Oracle Corporation (US), IBM (US), Carestream Health (US), Wolters Kluwer N.V. (Netherlands), Epic Systems Corporation (US), Chang Healthcare (US), Medical Information Technology, Inc. (US), and Computer Programs and Systems, Inc (US) are among the key companies in the Clinical Decision Support System Market.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

  • 2.1 DEFINITION
  • 2.2 SCOPE OF THE STUDY
  • 2.3 RESEARCH OBJECTIVE
  • 2.4 MARKET STRUCTURE

3 RESEARCH METHODOLOGY

  • 3.1 OVERVIEW
  • 3.2 DATA FLOW
    • 3.2.1 DATA MINING PROCESS
  • 3.3 PURCHASED DATABASE:
  • 3.4 SECONDARY SOURCES:
    • 3.4.1 SECONDARY RESEARCH DATA FLOW:
  • 3.5 PRIMARY RESEARCH:
    • 3.5.1 PRIMARY RESEARCH DATA FLOW:
    • 3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED
  • 3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
    • 3.6.1 REVENUE ANALYSIS APPROACH
  • 3.7 DATA FORECASTING
    • 3.7.1 DATA FORECASTING TECHNIQUE
  • 3.8 DATA MODELING
    • 3.8.1 MICROECONOMIC FACTOR ANALYSIS:
    • 3.8.2 DATA MODELING:
  • 3.9 TEAMS AND ANALYST CONTRIBUTION

4 MARKET DYNAMICS

  • 4.1 INTRODUCTION
  • 4.2 DRIVERS
    • 4.2.1 RISING GERIATRIC POPULATION
    • 4.2.2 FAVORABLE GOVERNMENT REGULATIONS
    • 4.2.3 GROWING DEMAND FOR DATA-DRIVEN TECHNOLOGIES
  • 4.3 RESTRAINT
    • 4.3.1 RISK OF DATA PRIVACY
    • 4.3.2 HIGH COST OF IMPLEMENTATION
  • 4.4 OPPORTUNITIES
    • 4.4.1 ADVANCEMENTS IN THE HEALTHCARE IT SECTOR

5 MARKET FACTOR ANALYSIS

  • 5.1 VALUE CHAIN ANALYSIS
    • 5.1.1 INPUTS
    • 5.1.2 DESIGN & DEVELOPMENT
    • 5.1.3 OUTPUT
    • 5.1.4 SALES & DISTRIBUTION
    • 5.1.5 POST-SALES SERVICES
  • 5.2 PORTER'S FIVE FORCES MODEL
    • 5.2.1 BARGAINING POWER OF SUPPLIERS
    • 5.2.2 BARGAINING POWER OF BUYERS
    • 5.2.3 THREAT OF NEW ENTRANTS
    • 5.2.4 THREAT OF SUBSTITUTES
    • 5.2.5 INTENSITY OF RIVALRY
  • 5.3 IMPACT OF COVID-19 ON THE GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET
    • 5.3.1 OVERVIEW
    • 5.3.2 IMPACT ON SUPPLY CHAIN
    • 5.3.3 IMPACT ON DEVELOPMENT
    • 5.3.4 IMPACT ON REGIONS
    • 5.3.5 MANAGING POST-COVID CARE THROUGH CLINICAL DECISION SUPPORT SYSTEMS

6 GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET, BY PRODUCT

  • 6.1 OVERVIEW
  • 6.2 SOFTWARE
  • 6.3 SERVICES
  • 6.4 HARDWARE

7 GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET, BY PRODUCT

  • 7.1 OVERVIEW
  • 7.2 INTEGRATED CDSS
  • 7.3 STANDALONE CDSS

8 GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET, BY MODEL

  • 8.1 OVERVIEW
  • 8.2 KNOWLEDGE-BASED CDSS
  • 8.3 NON-KNOWLEDGE-BASED CDSS

9 GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET, BY DELIVERY MODE

  • 9.1 OVERVIEW
  • 9.2 ON-PREMISE CDSS
  • 9.3 CLOUD-BASED CDSS

10 GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET, BY MODE OF ADVICE

  • 10.1 OVERVIEW
  • 10.2 ACTIVE CDSS
  • 10.3 PASSIVE CDSS

11 GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET, BY SETTING

  • 11.1 OVERVIEW
  • 11.2 INPATIENT SETTINGS
  • 11.3 AMBULATORY CARE SETTINGS

12 GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET, BY TYPE

  • 12.1 OVERVIEW
  • 12.2 THERAPEUTIC CDSS
  • 12.3 DIAGNOSTIC CDSS

13 GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET, BY APPLICATION

  • 13.1 OVERVIEW
  • 13.2 ADVANCED CDSS
  • 13.3 CONVENTIONAL CDSS

14 GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET, BY REGION

  • 14.1 OVERVIEW
  • 14.2 NORTH AMERICA
    • 14.2.1 US
    • 14.2.2 CANADA
  • 14.3 EUROPE
    • 14.3.1 GERMANY
    • 14.3.2 FRANCE
    • 14.3.3 UK
    • 14.3.4 ITALY
    • 14.3.5 SPAIN
    • 14.3.6 REST OF EUROPE
  • 14.4 ASIA-PACIFIC
    • 14.4.1 CHINA
    • 14.4.2 JAPAN
    • 14.4.3 INDIA
    • 14.4.4 AUSTRALIA
    • 14.4.5 SOUTH KOREA
    • 14.4.6 REST OF ASIA-PACIFIC
  • 14.5 REST OF THE WORLD
    • 14.5.1 MIDDLE EAST & AFRICA
    • 14.5.2 LATIN AMERICA

15 COMPETITIVE LANDSCAPE

  • 15.1 INTRODUCTION
  • 15.2 MARKET SHARE ANALYSIS,
  • 15.3 COMPETITOR DASHBOARD
  • 15.4 PUBLIC PLAYERS STOCK SUMMARY
  • 15.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
  • 15.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
    • 15.6.1 /PRODUCT/SOLUTION/SERVICE LAUNCHAPPROVAL
    • 15.6.2 COLLABORATION
    • 15.6.3 ACQUISITION
    • 15.6.4 PARTNERSHIP

16 COMPANY PROFILES

  • 16.1 SIEMENS
    • 16.1.1 COMPANY OVERVIEW
    • 16.1.2 FINANCIAL OVERVIEW
    • 16.1.3 PRODUCTS OFFERED
    • 16.1.4 KEY DEVELOPMENTS
    • 16.1.5 SWOT ANALYSIS
    • 16.1.6 KEY STRATEGIES
  • 16.2 VERADIGM LLC (ALLSCRIPTS HEALTHCARE SOLUTIONS INC)
    • 16.2.1 COMPANY OVERVIEW
    • 16.2.2 FINANCIAL OVERVIEW
    • 16.2.3 PRODUCTS OFFERED
    • 16.2.4 KEY DEVELOPMENTS
    • 16.2.5 SWOT ANALYSIS
    • 16.2.6 KEY STRATEGIES
  • 16.3 ORACLE CORPORATION
    • 16.3.1 COMPANY OVERVIEW
    • 16.3.2 FINANCIAL OVERVIEW
    • 16.3.3 PRODUCTS OFFERED
    • 16.3.4 KEY DEVELOPMENTS
    • 16.3.5 KEY STRATEGIES
  • 16.4 IBM
    • 16.4.1 COMPANY OVERVIEW
    • 16.4.2 FINANCIAL OVERVIEW
    • 16.4.3 SOLUTION OFFERED
    • 16.4.4 KEY DEVELOPMENTS
    • 16.4.5 SWOT ANALYSIS
    • 16.4.6 KEY STRATEGIES
  • 16.5 CARESTREAM HEALTH
    • 16.5.1 COMPANY OVERVIEW
    • 16.5.2 FINANCIAL OVERVIEW
    • 16.5.3 SERVICE/SOLUTION OFFERED
    • 16.5.4 KEY DEVELOPMENTS
    • 16.5.5 KEY STRATEGIES
  • 16.6 WOLTERS KLUWER N.V.
    • 16.6.1 COMPANY OVERVIEW
    • 16.6.2 FINANCIAL OVERVIEW
    • 16.6.3 PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • 16.6.4 KEY DEVELOPMENTS
    • 16.6.5 SWOT ANALYSIS
    • 16.6.6 KEY STRATEGIES
  • 16.7 EPIC SYSTEMS CORPORATION
    • 16.7.1 COMPANY OVERVIEW
    • 16.7.2 FINANCIAL OVERVIEW
    • 16.7.3 PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • 16.7.4 KEY DEVELOPMENTS
    • 16.7.5 SWOT ANALYSIS
    • 16.7.6 KEY STRATEGIES
  • 16.8 CHANG HEALTHCARE
    • 16.8.1 COMPANY OVERVIEW
    • 16.8.2 FINANCIAL OVERVIEW
    • 16.8.3 PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • 16.8.4 KEY DEVELOPMENTS
    • 16.8.5 KEY STRATEGIES
  • 16.9 MEDICAL INFORMATION TECHNOLOGY, INC.
    • 16.9.1 COMPANY OVERVIEW
    • 16.9.2 FINANCIAL OVERVIEW
    • 16.9.3 PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • 16.9.4 KEY DEVELOPMENTS
    • 16.9.5 KEY STRATEGIES
  • 16.10 COMPUTER PROGRAMS AND SYSTEMS, INC.
    • 16.10.1 COMPANY OVERVIEW
    • 16.10.2 FINANCIAL OVERVIEW
    • 16.10.3 PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • 16.10.4 KEY DEVELOPMENTS
    • 16.10.5 KEY STRATEGIES

17 DATA CITATIONS